Page 48 - Read Online

Page 20 of 22 Strassheim et al. Vessel Plus 2018;2:29 I http://dx.doi.org/10.20517/2574-1209.2018.44

191. Liao X, Shen Y, Zhang R, Sugi K, Vasudevan NT, Alaiti MA, Sweet DR, Zhou L, Qing Y, Gerson SL, Fu C, Wynshaw-Boris A, Hu
R, Schwartz MA, Fujioka H, Richardson B, Cameron MJ, Hayashi H, Stamler JS, Jain MK. Distinct roles of resident and nonresident
macrophages in nonischemic cardiomyopathy. Proc Natl Acad Sci U S A 2018;115:E4661-9.
192. Renaud-Gabardos E, Tatin F, Hantelys F, Lebas B, Calise D, Kunduzova O, Masri B, Pujol F, Sicard P, Valet P, Roncalli J, Chaufour X,
Garmy-Susini B, Parini A, Prats AC. Therapeutic benefit and gene network regulation by combined gene transfer of apelin, FGF2, and
SERCA2a into ischemic heart. Mol Ther 2018;26:902-16.
193. Dewachter C, Belhaj A, Rondelet B, Vercruyssen M, Schraufnagel DP, Remmelink M, Brimioulle S, Kerbaul F, Naeije R, Dewachter
L. Myocardial inflammation in experimental acute right ventricular failure: effects of prostacyclin therapy. J Heart Lung Transplant
2015;34:1334-45.
194. Wu L, Gao L, Zhang D, Yao R, Huang Z, Du B, Wang Z, Xiao L, Li P, Li Y, Liang C, Zhang Y. C1QTNF1 attenuates angiotensin II-
induced cardiac hypertrophy via activation of the AMPKa pathway. Free Radic Biol Med 2018;121:215-30.
195. Chien PT, Lin CC, Hsiao LD, Yang CM. Induction of HO-1 by carbon monoxide releasing molecule-2 attenuates thrombin-induced
COX-2 expression and hypertrophy in primary human cardiomyocytes. Toxicol Appl Pharmacol 2015;289:349-59.
196. Ramos-Kuri M, Rapti K, Mehel H, Zhang S, Dhandapany PS, Liang L, Garcia-Carranca A, Bobe R, Fischmeister R, Adnot S, Lebeche D,
Hajjar RJ, Lipskaia L, Chemaly ER. Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac
hypertrophy. Biochim Biophys Acta 2015;1853:2870-84.
197. Cortes R, Rivera M, Rosello-Lleti E, Martinez-Dolz L, Almenar L, Azorin I, Lago F, Gonzalez-Juanatey JR, Portoles M. Differences in
MEF2 and NFAT transcriptional pathways according to human heart failure aetiology. PLoS One 2012;7:e30915.
198. Aguero J, Ishikawa K, Hadri L, Santos-Gallego C, Fish K, Hammoudi N, Chaanine A, Torquato S, Naim C, Ibanez B, Pereda D, Garcia-
Alvarez A, Fuster V, Sengupta PP, Leopold JA, Hajjar RJ. Characterization of right ventricular remodeling and failure in a chronic
pulmonary hypertension model. Am J Physiol Heart Circ Physiol 2014;307:H1204-15.
199. Huang J, Chen L, Yao Y, Tang C, Ding J, Fu C, Li H, Ma G. Pivotal role of regulator of G-protein signaling 12 in pathological cardiac
hypertrophy. Hypertension 2016;67:1228-36.
200. Ramadas N, Rajaraman B, Kuppuswamy AA, Vedantham S. Early growth response-1 (EGR-1) - a key player in myocardial cell injury.
Cardiovasc Hematol Agents Med Chem 2014;12:66-71.
201. van der Feen DE, Dickinson MG, Bartelds B, Borgdorff MA, Sietsma H, Levy M, Berger RM. Egr-1 identifies neointimal remodeling
and relates to progression in human pulmonary arterial hypertension. J Heart Lung Transplant 2016;35:481-90.
202. Dickinson MG, Kowalski PS, Bartelds B, Borgdorff MA, van der Feen D, Sietsma H, Molema G, Kamps JA, Berger RM. A critical role
for Egr-1 during vascular remodelling in pulmonary arterial hypertension. Cardiovasc Res 2014;103:573-84.
203. Lemon DD, Harrison BC, Horn TR, Stratton MS, Ferguson BS, Wempe MF, McKinsey TA. Promiscuous actions of small molecule
inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle. FEBS Lett 2015;589:1080-8.
204. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, McKinsey TA. Protein kinases C and D mediate agonist-
dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 2004;24:8374-85.
205. Yang L, Yu D, Mo R, Zhang J, Hua H, Hu L, Feng Y, Wang S, Zhang WY, Yin N, Mo XM. The succinate receptor GPR91 is involved in
pressure overload-induced ventricular hypertrophy. PLoS One 2016;11:e0147597.
206. Yang L, Yu D, Fan HH, Feng Y, Hu L, Zhang WY, Zhou K, Mo XM. Triggering the succinate receptor GPR91 enhances pressure
overload-induced right ventricular hypertrophy. Int J Clin Exp Pathol 2014;7:5415-28.
207. Deschamps AM, Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol
Heart Circ Physiol 2009;297:H1806-13.
208. Bopassa JC, Eghbali M, Toro L, Stefani E. A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening
and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2010;298:H16-23.
209. Nunn C, Zou MX, Sobiesiak AJ, Roy AA, Kirshenbaum LA, Chidiac P. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte
hypertrophy. Cell Signal 2010;22:1231-9.
210. Lee KN, Lu X, Nguyen C, Feng Q, Chidiac P. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G
protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice. J Mol Cell Cardiol
2017;108:194-202.
211. Sjogren B, Parra S, Atkins KB, Karaj B, Neubig RR. Digoxin-mediated upregulation of RGS2 protein protects against cardiac injury. J
Pharmacol Exp Ther 2016;357:311-9.
212. Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, Nagayama T, Bedja D, Gabrielson KL, Blanton R, Siderovski DP, Mendelsohn
ME, Kass DA. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of
PDE5 inhibition in mice. J Clin Invest 2009;119:408-20.
213. Tokudome T, Kishimoto I, Horio T, Arai Y, Schwenke DO, Hino J, Okano I, Kawano Y, Kohno M, Miyazato M, Nakao K, Kangawa
K. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Circulation 2008;117:2329-39.
214. Yang J, Maity B, Huang J, Gao Z, Stewart A, Weiss RM, Anderson ME, Fisher RA. G-protein inactivator RGS6 mediates myocardial
cell apoptosis and cardiomyopathy caused by doxorubicin. Cancer Res 2013;73:1662-7.
215. Miao R, Lu Y, Xing X, Li Y, Huang Z, Zhong H, Huang Y, Chen AF, Tang X, Li H, Cai J, Yuan H. Regulator of G-protein signaling 10
negatively regulates cardiac remodeling by blocking mitogen-activated protein kinase-extracellular signal-regulated protein kinase 1/2
signaling. Hypertension 2016;67:86-98.
216. Li Y, Tang XH, Li XH, Dai HJ, Miao RJ, Cai JJ, Huang ZJ, Chen AF, Xing XW, Lu Y, Yuan H. Regulator of G protein signalling 14